Skip to Main Content
  • Become an Access Reviewer
  • Clinical Phenotypes
  • OMMBID Advisory banner
  • Ommbid banner
  • Ommbid latest banner



  1. Gene expression profiling is a powerful new approach for viewing the expression of many genes simultaneously in different types of malignant or normal cells. Using computational approaches, differentially expressed genes or informative patterns of expressed genes are mined from large data sets produced by new expression profiling technology. This technology yields the opportunity to classify tumors by gene expression and to locate genes of diagnostic or therapeutic importance.

  2. DNA array technology uses thousands of DNA fragments arrayed on a solid surface in order to probe many messenger ribonucleic acid (mRNA) levels in one experiment. Both oligonucleotides and portions of complementary deoxyribonucleic acid (cDNA) are used as hybridization probes on the arrays. Clustering and other statistical based algorithms are used to locate patterns of gene expression of importance when analyzing large numbers of RNA samples.

  3. Serial Analysis of Gene Expression (SAGE) is a sequencing based technology that provides an in-depth quantitative assessment of gene expression. SAGE works by counting transcripts and storing digital values electronically, providing absolute gene expression levels that make historical comparisons and databasing facile. It is useful for studying small numbers of tissue or cellular samples derived from well-controlled experiments.

  4. Gene expression profiling techniques have been used to obtain global gene expression patterns from several common malignancies and corresponding normal tissues. These studies highlight the potential of gene expression profiling in cancer taxonomy, and in the identification of molecular targets for diagnosis and therapy.

  5. Gene expression profiling has been used in the dissection of specific oncogenic molecular pathways, including the p53 tumor-suppressor pathway, the APC/β-catenin pathway, and numerous in vitro and in vivo models of angiogenesis and cancer drug resistance.

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

OMMBID Full Site: One-Year Subscription

Connect to the full suite of OMMBID content including new and revised chapters that reflect the latest research, image galleries, clinical phenotypes, and more.

$295 USD
Buy Now

Pay Per View: Timed Access to all of OMMBID

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.